Characteristics | PH positive group (n = 26) | PH negative group (n = 109) | P-value |
---|---|---|---|
INR at the day of implanta | 2.1 (2.0–2.5) | 2.0 (1.9–2.5) | 0.122 |
Generator exchange and/or pocket revision, n (%) | 3 (11.5) | 11 (10.1) | 1.0 |
New implantation, n (%) | 19 (73.1) | 82 (75.2) | 1.0 |
Upgrade and/or lead revision, n (%) | 4 (15.4) | 16 (14.7) | 1.0 |
Pacemaker, n (%) | 1 (3.8) | 23 (21.1) | 0.045 |
ICD, n (%) | 25 (96.2) | 86 (78.9) | |
Number of leads implanted | |||
One, n (%) | 2 (7.7) | 24 (22.0) | 0.165 |
Two, n (%) | 8 (30.8) | 42 (38.5) | 0.610 |
Three, n (%) | 13 (50.0) | 32 (29.4) | 0.076 |
Submuscular pocket, n (%) | 1 (3.8) | 4 (3.7) | 1.0 |
Venous route other than subclavian | |||
Axillary, n (%) | 3 (11.5) | 9 (8.3) | 0.700 |
Cephalic, n (%) | 2 (7.7) | 5 (4.6) | 0.620 |
Local tranexamic acid use | 4 (15.4) | 48 (44.0) | 0.013 |